For example, low gene expression levels of ERCC1 were associated with a superior response to 5-FU and cisplatin chemotherapy (FP) in primary gastric cancer (Metzger et al, 1998), and ERCC1 protein expression levels were found to be inversely associated with response. The gene discussed is ERCC1; the disease is gastric cancer.